OCLNP1

Across TCGA pan-cancer cohorts, OCLNP1 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of OCLNP1’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where OCLNP1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OCLNP1 is over-expressed in tumor, although a few such as LUSC and KICH show the opposite, repressed pattern.

LIHC, LUSC, and KICH are the cancer types where OCLNP1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OCLNP1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	+0.294	.018	3	view →
LUSC	All	All	−0.403	.012	2	view →
KICH	All	All	−0.400	.008	2	view →
COAD	Female	All	−0.224	.025	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

OCLNP1–LIHC

Open the LIHC breakdown →